Navigation Links
Paralyzed Artist Launches WillWalk Foundation to Cure Paralysis with Breakthrough Stem Cell Research
Date:9/14/2009

AUSTIN, Texas, Sept. 14 /PRNewswire/ -- WillWalk, an Austin based non-profit organization has committed itself to be at the forefront of ending Paralysis. WillWalk will raise $3 million to help fund the first non-controversial human stem cell trials for people with Spinal Cord Injury (SCI).

The money raised will fund the first of this kind of research in the U.S. The stem cells being used are a non-controversial adult stem cell from umbilical cord blood. These studies will be a landmark achievement in medicine and will be the first time stem cells are used on humans to treat chronic SCI.

Dr. Wise Young from the Keck Institute in New Jersey, is currently collaborating with doctors in Austin to work on conducting trials at the Brackenridge Brain and Spine Center in Austin, TX in conjunction with the Lone Star Paralysis Foundation. Initially, the trials will involve 30 patients of which a portion will be treated with the stem cells, and with Lithium to promote neuron growth, and extensive rehabilitation.

"Through our work with The University of Texas and University Medical Center Brackenridge, we will solve one of man's greatest medical challenges -- curing paralysis. Conducting ground-breaking SCI research will make Austin's Brackenridge one of the 5 major spinal cord centers in North America," said Doug English, President, Lonestar Paralysis Foundation.

The vision of the WillWalk Foundation came about when Marty Butler and Jared Dunten's lives were inextricably woven together after a camping trip in 2000 where Jared dove into the Rio Grande, hit a sand bar and broke his neck at the C4-5 level. Marty went into the water resuscitated him. Their shared passion for art coupled with Jared's unwillingness to fully accept life as a quadriplegic was the seedling that formed WillWalk. "Our vision is to communicate the idea that paralysis is unacceptable and the time has come for a cure," said Founder, Jared Dunten. Their first collaborative art exhibit debuted at The University of Texas Bass Concert Hall in March 2009. The exhibit is currently being auctioned on the foundation web site www.Willwalk.org. Proceeds will fund this groundbreaking research.

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.


'/>"/>
SOURCE WillWalk Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Tickets On Sale Now: Bridge to Hope All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Masons Great Meadow
2. Artists for a New South Africa Will be Shaking The Blues at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb Mo, Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles
3. NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections
4. Karolinska Development Portfolio Company Launches GMP Facility for Particulate Manufacturing
5. Vision Inspection Systems Specialist Acquire Automation Expands Employee Base, Launches New Web Site
6. Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
7. Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
8. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
9. National Hemovigilance Pilot Program Launches to Track Adverse Events Associated with Blood Transfusion
10. TriLink Launches CleanAmp(TM) dNTPs for Hot Start PCR
11. Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... (FDA) has agreed to schedule an End-of-Phase II meeting ... of its oral insulin capsule ORMD-0801 in the treatment ... primary and secondary endpoints by indicating a statistically significant ...
(Date:7/10/2017)... July 10, 2017  The tenth annual BioPharm ... MA at the Sheraton Boston Hotel, September ... access to global decision makers and innovative biotech startup ... science leaders during two impactful days. BioPharm America is ... with additional networking opportunities with 4,500+ life science industry ...
(Date:7/5/2017)... , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company focused ... that it has received approval from the Israel Securities Authority ... Exchange (TASE). Oramed common stock will commence trading on the ... on the current market capitalization of the Company, it is ...
Breaking Medicine Technology:
(Date:7/23/2017)... ... July 23, 2017 , ... Scientists from the University of Exeter ... high-intensity, weight-bearing activity equivalent to a medium-paced run for pre-menopausal women, or a slow ... specializes in total spine care, I understand the importance exercise can play on improving ...
(Date:7/23/2017)... ... July 23, 2017 , ... ... Florida Pain Relief Group – Melbourne, a practice owned by Physician Partners of ... interventional pain management, Dr. Stern also is certified in pediatrics, emergency medicine and ...
(Date:7/22/2017)... ... July 22, 2017 , ... The arthroscopic ... repairs the opportunity to return to sports and jobs that require heavy physical ... Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. , “We studied ...
(Date:7/21/2017)... ... July 21, 2017 , ... Roderick Crabbe Insurance, ... to families and business owners in northern Florida, is joining the First Coast ... to area adults with developmental challenges. , The First Coast YMCA offers assistance ...
(Date:7/21/2017)... ... July 21, 2017 , ... Hospital M&A activity slowed in the second ... of hospital acquisitions rose to 23 in the second quarter, up 15% from the ... the 20 announced deals in the year-ago second quarter. Only four of the transactions ...
Breaking Medicine News(10 mins):